Seung Jae Hyeon Selected Research

Chronic Traumatic Encephalopathy

4/2023	Lipocalin-2 Is a Key Regulator of Neuroinflammation in Secondary Traumatic and Ischemic Brain Injury.
1/2021	Hevin-calcyon interaction promotes synaptic reorganization after brain injury.
1/2017	Transcriptome analyses of chronic traumatic encephalopathy show alterations in protein phosphatase expression associated with tauopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Seung Jae Hyeon Research Topics

Disease

9	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 01/2017
4	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2022 - 01/2022
4	Huntington Disease (Huntington's Disease) 01/2022 - 11/2017
3	Chronic Traumatic Encephalopathy 04/2023 - 01/2017
3	Cognitive Dysfunction 01/2023 - 02/2020
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 07/2022 - 02/2021
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 01/2018
2	Brain Injuries (Brain Injury) 04/2023 - 01/2021
2	Traumatic Brain Injuries (Traumatic Brain Injury) 04/2023 - 01/2021
2	Gliosis 01/2023 - 01/2022
1	Tremor (Tremors) 08/2023
1	Neuroinflammatory Diseases 04/2023
1	Body Weight (Weight, Body) 12/2022
1	Mental Disorders (Mental Disorder) 01/2022
1	Memory Disorders (Memory Loss) 01/2022
1	Inflammation (Inflammations) 04/2021
1	Brain Diseases (Brain Disorder) 02/2021
1	Neuroblastoma 01/2021
1	Craniocerebral Trauma (Head Injury) 01/2020
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2019
1	Parkinson Disease (Parkinson's Disease) 11/2018
1	Tauopathies 01/2017

Drug/Important Bio-Agent (IBA)

3	Amyloid (Amyloid Fibrils)IBA 01/2023 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 04/2023 - 01/2022
2	gamma-Aminobutyric Acid (GABA)IBA 01/2023 - 01/2022
2	AntioxidantsIBA 07/2022 - 02/2021
2	Amyloid beta-PeptidesIBA 01/2022 - 01/2022
2	HeterochromatinIBA 12/2021 - 11/2017
1	Dihydrotachysterol (AT 10)IBA 08/2023
1	Messenger RNA (mRNA)IBA 04/2023
1	Lipocalin-2IBA 04/2023
1	Neutralizing AntibodiesIBA 04/2023
1	Acetates (Acetic Acid Esters)FDA Link 01/2023
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	SpermidineIBA 12/2022
1	paeonolIBA 07/2022
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2022
1	Neuroprotective AgentsIBA 01/2022
1	OrnithineIBA 01/2022
1	Methyl-CpG-Binding Protein 2IBA 01/2022
1	polyglutamineIBA 01/2022
1	PutrescineIBA 01/2022
1	Urea (Carbamide)FDA LinkGeneric 01/2022
1	AmmoniaIBA 01/2022
1	Glutamic Acid (Glutamate)FDA Link 04/2021
1	CitrullineIBA 02/2021
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	calcyonIBA 01/2021
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2021
1	X-Linked Inhibitor of Apoptosis ProteinIBA 01/2021
1	quinolineIBA 01/2021
1	Methylene Blue (Methylthioninium Chloride)FDA Link 02/2020
1	Calcium-Calmodulin-Dependent Protein KinasesIBA 01/2020
1	AMPA Receptors (AMPA Receptor)IBA 01/2020
1	Protein Kinase CIBA 01/2020
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2020
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2020
1	Histones (Histone)IBA 01/2020
1	tau Proteins (tau Protein)IBA 01/2020
1	RNA-Binding Protein EWSIBA 01/2019
1	Leucine (L-Leucine)FDA Link 11/2018
1	Phosphotransferases (Kinase)IBA 11/2018
1	Sirtuin 3IBA 01/2018
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2017
1	Histone Deacetylase 6IBA 01/2017

Therapy/Procedure

1	Therapeutics 01/2022